Pharmaceutical Executive June 9, 2021
Julian Upton

How the UK is making progress in this hi-tech field.

Pharmaceutical 3D printing research has developed rapidly in the past five years; these days, numerous papers describing the development of novel 3D printable formulations using different drugs, excipients, and designs are published each month. The UK has been making particular headway in pushing this research forward. For example, FabRx, a spin-out from University College London (UCL), is the first company to focus on bringing 3D printing technology to the clinical setting. Last month, researchers from the University of East Anglia (UAE) announced they had identified a new method for the 3D printing of medicine in highly porous structures, with promising implications for the future manufacture of personalized medicine.

FabRx carries...

Today's Sponsors

Patient Bond
Institute for Healthcare Improvement

Today's Sponsors

Oliver Wyman
Patient Bond

Today's Sponsor

Patient Bond

Topics: 3D Printing, Pharma / Biotech, Precision Medicine, Technology
CIOs' 5-year plans for precision medicine and emerging technologies
Implementing Responsible AI to Drive Innovation in Clinical Research & Precision Medicine
Payer Perspective: Adapting to Precision Medicine in Cancer Care
StartUp Health Insights: Precision Medicine Leads the Week’s Health Innovation Funding | Week of…
Precision Medicine, Omics, and the Black Box